Results 101 to 110 of about 9,091 (172)

A case report on the effective and safe use of ravulizumab in atypical hemolytic uremic syndrome during pregnancy. [PDF]

BMC Nephrol
Alkhaldi A, Elawad M, Al Dalbhi S, Alquraini B, Alshannan A.   +4 more
europepmc   +1 more source

The KLF4-CD46 axis: a novel therapeutic target in transplant-associated thrombotic microangiopathy and beyond. [PDF]

Haematologica
Cugno M, Lämmle B.
europepmc   +1 more source

Hidden in the Kidney: Renal-Limited Thrombotic Microangiopathy Without Hemolysis. [PDF]

Kidney Int Rep
Keratishvili D, Alam SF, Galeano BK, Godby RC, Alexander MP, Bentall AJ.   +5 more
europepmc   +1 more source

Complement and transplant-associated thrombotic microangiopathy: Current and future approaches. [PDF]

Hemasphere
Cugno M, Onida F, Lämmle B.
europepmc   +1 more source

Liver Xenotransplantation: From Early Primate Trials to the First-in-Human Porcine Bridging Therapies. [PDF]

J Clin Med
Nastase AG, Vasilescu AM, Trofin AM, Iftimie NF, Segura-Sampedro JJ, Cadar R, Buzincu I, Davidescu A, Nastase AL, Briceanu OG, Lupascu-Ursulescu C, Lupascu CD.   +11 more
europepmc   +1 more source

The Complosome: An Emerging Intracellular Complement Network in Cancer Development and Therapy. [PDF]

Int J Mol Sci
Zadroga Ł, Lewandowski F, Bębnowska D, Majchrzak A, Czyż A, Niedźwiedzka-Rystwej P.   +5 more
europepmc   +1 more source

Complement-mediated HUS revisited: evolving insights into pathophysiology, diagnosis, and treatment. [PDF]

Front Immunol
Alyamany R, Moyer AM, Willrich MAV, Sridharan M.   +3 more
europepmc   +1 more source

Tropism, replication competence, and cellular responses of HAdV-14p1 in human airway organoids. [PDF]

iScience
Guo W, Yang Y, Liang Y, Cui F, Li L, Peng X, Zhou J, Li Y, Deng Y, Wang Y, Chen R, Wen T, Lin C, Lin W, Liu L, Lin Y, Chen Q.   +16 more
europepmc   +1 more source

Adhesion molecules provide an endothelial protein signature in preclinical and clinical Alzheimer's disease and predict clinical progression. [PDF]

Commun Med (Lond)
Hajjar IM, Neal R, Singh N, Yang Z, Obideen M, Shah AM, Dammer EB.   +6 more
europepmc   +1 more source

Antibody-drug conjugates in prostate cancer: current landscape and future directions. [PDF]

Ther Adv Med Oncol
Ozay ZI, Hage Chehade C, Gebrael G, Ostrowski M, Sayegh N, Swami U, Agarwal N.   +6 more
europepmc   +1 more source